Rojas_Manual de retina

97

Capítulo 21 Fisiopatología de la retinopatía diabética

Bibliografía consultada

Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol . 2002;86:363-5. Gao BB, Clermont A, Rook S et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med . 2007;13:181-8. Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin N Am . 2004;88:1001-36. Klein R, Klein BE, Moss SE et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Preva lence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol . 1984;102:527-32. Klein R, Klein BE, Moss SE et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Preva lence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol . 1984;102:520-6. Stephen JR. Retina. 5th ed. Philadelphia; Elsevier Saunders. 2013. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin-dependent diabetes mellitus. N Engl J Med . 1993;329:977-86. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. Wallow IH, Engerman RL. Permeability and patency of retinal blood vessels in experimental diabetes. Invest Ophthalmol Vis Sci. 1977;16:447-61. Yilmaz T, Weaver CD, Gallagher MJ et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology . 2009;116:902-11.

SII

SAMPLE